115 related articles for article (PubMed ID: 17622740)
21. Renal remodelling in dietary protein modified rat polycystic kidney disease.
Bankovic-Calic N; Eddy A; Sareen S; Ogborn MR
Pediatr Nephrol; 1999 Sep; 13(7):567-70. PubMed ID: 10460502
[TBL] [Abstract][Full Text] [Related]
22. Effect of dietary soy protein and genistein on disease progression in mice with polycystic kidney disease.
Tomobe K; Philbrick DJ; Ogborn MR; Takahashi H; Holub BJ
Am J Kidney Dis; 1998 Jan; 31(1):55-61. PubMed ID: 9428452
[TBL] [Abstract][Full Text] [Related]
23. The effect of dietary flaxseed supplementation on organic anion and osmolyte content and excretion in rat polycystic kidney disease.
Ogborn MR; Nitschmann E; Bankovic-Calic N; Buist R; Peeling J
Biochem Cell Biol; 1998; 76(2-3):553-9. PubMed ID: 9923725
[TBL] [Abstract][Full Text] [Related]
24. Feeding soy protein isolate and n-3 PUFA affects polycystic liver disease progression in a PCK rat model of autosomal polycystic kidney disease.
Maditz KH; Benedito VA; Oldaker C; Nanda N; Lateef SS; Livengood R; Tou JC
J Pediatr Gastroenterol Nutr; 2015 Apr; 60(4):467-73. PubMed ID: 25822773
[TBL] [Abstract][Full Text] [Related]
25. Dietary soya protein during pregnancy and lactation in rats with hereditary kidney disease attenuates disease progression in offspring.
Cahill LE; Peng CY; Bankovic-Calic N; Sankaran D; Ogborn MR; Aukema HM
Br J Nutr; 2007 Jan; 97(1):77-84. PubMed ID: 17217562
[TBL] [Abstract][Full Text] [Related]
26. Targeting of sodium-glucose cotransporters with phlorizin inhibits polycystic kidney disease progression in Han:SPRD rats.
Wang X; Zhang S; Liu Y; Spichtig D; Kapoor S; Koepsell H; Mohebbi N; Segerer S; Serra AL; Rodriguez D; Devuyst O; Mei C; Wüthrich RP
Kidney Int; 2013 Nov; 84(5):962-8. PubMed ID: 23715121
[TBL] [Abstract][Full Text] [Related]
27. Feeding soy protein isolate and oils rich in omega-3 polyunsaturated fatty acids affected mineral balance, but not bone in a rat model of autosomal recessive polycystic kidney disease.
Maditz KH; Smith BJ; Miller M; Oldaker C; Tou JC
BMC Nephrol; 2015 Feb; 16():13. PubMed ID: 25886405
[TBL] [Abstract][Full Text] [Related]
28. Amelioration of polycystic kidney disease by modification of dietary protein intake in the rat.
Ogborn MR; Sareen S
J Am Soc Nephrol; 1995 Dec; 6(6):1649-54. PubMed ID: 8749693
[TBL] [Abstract][Full Text] [Related]
29. Distinctive effects of plant protein sources on renal disease progression and associated cardiac hypertrophy in experimental kidney disease.
Aukema HM; Gauthier J; Roy M; Jia Y; Li H; Aluko RE
Mol Nutr Food Res; 2011 Jul; 55(7):1044-51. PubMed ID: 21294251
[TBL] [Abstract][Full Text] [Related]
30. Dietary flax oil rich in α-linolenic acid reduces renal disease and oxylipin abnormalities, including formation of docosahexaenoic acid derived oxylipins in the CD1-pcy/pcy mouse model of nephronophthisis.
Yamaguchi T; Devassy JG; Gabbs M; Ravandi A; Nagao S; Aukema HM
Prostaglandins Leukot Essent Fatty Acids; 2015 Mar; 94():83-9. PubMed ID: 25512022
[TBL] [Abstract][Full Text] [Related]
31. Dietary modulation of p-nonylphenol-induced polycystic kidneys in male Sprague-Dawley rats.
Cooper S; Latendresse JR; Doerge DR; Twaddle NC; Fu X; Delclos KB
Toxicol Sci; 2006 Jun; 91(2):631-42. PubMed ID: 16554316
[TBL] [Abstract][Full Text] [Related]
32. Dietary betaine modifies hepatic metabolism but not renal injury in rat polycystic kidney disease.
Ogborn MR; Nitschmann E; Bankovic-Calic N; Buist R; Peeling J
Am J Physiol Gastrointest Liver Physiol; 2000 Dec; 279(6):G1162-8. PubMed ID: 11093938
[TBL] [Abstract][Full Text] [Related]
33. Methylprednisolone retards the progression of inherited polycystic kidney disease in rodents.
Gattone VH; Cowley BD; Barash BD; Nagao S; Takahashi H; Yamaguchi T; Grantham JJ
Am J Kidney Dis; 1995 Feb; 25(2):302-13. PubMed ID: 7847359
[TBL] [Abstract][Full Text] [Related]
34. Soy protein modification of rat polycystic kidney disease.
Ogborn MR; Bankovic-Calic N; Shoesmith C; Buist R; Peeling J
Am J Physiol; 1998 Mar; 274(3):F541-9. PubMed ID: 9530270
[TBL] [Abstract][Full Text] [Related]
35. Saskatoon berry supplementation prevents cardiac remodeling without improving renal disease in an animal model of reno-cardiac syndrome.
Raj P; Louis XL; Yu L; Siow YL; Suh M; Aukema HM; Netticadan T
J Food Biochem; 2021 Oct; 45(10):e13893. PubMed ID: 34459008
[TBL] [Abstract][Full Text] [Related]
36. Mycophenolate mofetil versus Rapamycin in Han: SPRD rats with Polycystic Kidney Disease.
Zhang T; Wang L; Xiong X; Mao Z; Wang L; Mei C
Biol Res; 2009; 42(4):437-44. PubMed ID: 20140299
[TBL] [Abstract][Full Text] [Related]
37. High dietary fat intake increases renal cyst disease progression in Han:SPRD-cy rats.
Jayapalan S; Saboorian MH; Edmunds JW; Aukema HM
J Nutr; 2000 Sep; 130(9):2356-60. PubMed ID: 10958835
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of mTOR with sirolimus slows disease progression in Han:SPRD rats with autosomal dominant polycystic kidney disease (ADPKD).
Wahl PR; Serra AL; Le Hir M; Molle KD; Hall MN; Wüthrich RP
Nephrol Dial Transplant; 2006 Mar; 21(3):598-604. PubMed ID: 16221708
[TBL] [Abstract][Full Text] [Related]
39. Rosiglitazone attenuates development of polycystic kidney disease and prolongs survival in Han:SPRD rats.
Dai B; Liu Y; Mei C; Fu L; Xiong X; Zhang Y; Shen X; Hua Z
Clin Sci (Lond); 2010 Jul; 119(8):323-33. PubMed ID: 20507283
[TBL] [Abstract][Full Text] [Related]
40. Altered ATP-sensitive P2 receptor subtype expression in the Han:SPRD cy/+ rat, a model of autosomal dominant polycystic kidney disease.
Turner CM; Ramesh B; Srai SK; Burnstock G; Unwin RJ
Cells Tissues Organs; 2004; 178(3):168-79. PubMed ID: 15655334
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
